Collegium Pharmaceutical (COLL) Income from Continuing Operations (2014 - 2026)
Collegium Pharmaceutical (COLL) reported Income from Continuing Operations of -$15.05 million for Q2 2026, compared with $11.98 million a year earlier.
Powered by 
Analysis
Collegium Pharmaceutical (COLL) Income from Continuing Operations (2014 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Collegium Pharmaceutical's Income from Continuing Operations came in at $47.92 million, up 32.1% year-over-year; for FY2025, it was $62.87 million, down 9.1% from FY2024.
- Income from Continuing Operations has a five-year compound annual growth rate of 18.6% (FY2020 to FY2025).
- By year, Income from Continuing Operations came in at $69.19 million in FY2024 (+43.7%), $48.16 million in FY2023, -$25 million in FY2022 and $71.52 million in FY2021 (+167.3%).
- The Q2 2026 figure ranks as the lowest quarterly Income from Continuing Operations since Q1 2023.
- Year over year, Income from Continuing Operations gained in three of the last seven quarters, with growth averaging 75.3%.
- The high point for year-over-year Income from Continuing Operations in five years was Q1 2026 (growth of 499.8%); the low point was Q3 2022 (a decline of 94.3%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $14.5 million (Q1 2026), $16.96 million (Q4 2025) and $31.51 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 5.53 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 3.62 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | -1.34 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 5.28 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 3.09 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 2.38 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -10.50 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -246.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 1.10 Bn |
| 10 | Collegium Pharmaceutical | 709.11 Mn | -514.65 Mn | 110.29 Mn | -15.05 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -15.05 Mn |
| Mar 31, 2026 | 14.50 Mn |
| Dec 31, 2025 | 16.96 Mn |
| Sep 30, 2025 | 31.51 Mn |
| Jun 30, 2025 | 11.98 Mn |
| Mar 31, 2025 | 2.42 Mn |
| Dec 31, 2024 | 12.54 Mn |
| Sep 30, 2024 | 9.34 Mn |
| Jun 30, 2024 | 19.61 Mn |
| Mar 31, 2024 | 27.71 Mn |
| Dec 31, 2023 | 31.94 Mn |
| Sep 30, 2023 | 20.63 Mn |
| Jun 30, 2023 | 13.01 Mn |
| Mar 31, 2023 | -17.43 Mn |
| Dec 31, 2022 | -7.20 Mn |
| Sep 30, 2022 | 457,000.00 |
| Jun 30, 2022 | -5.19 Mn |
| Mar 31, 2022 | -13.07 Mn |
| Dec 31, 2021 | -25.03 Mn |
| Sep 30, 2021 | 8.05 Mn |
API Access
Collegium Pharmaceutical Income from Continuing Operations API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=COLL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-continuing-operations", "ticker": "COLL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=COLL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();